Clinical Trial Update: Safety and Immunogenicity of Anti-Pneumococcal Vaccines in HIV-Infected Pregnant Women [Phase 2]

View source ↗

Summary

Phase 2 trial updating safety and immunogenicity of anti-pneumococcal vaccines in HIV-infected pregnant women has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV in Pregnant Women
• Pneumococcal Infection

Drugs mentioned

• PNC Vaccine

Snippet

Sponsor: Westat | Conditions: PNC Vaccine, HIV-infected Pregnant Women | Phase 2 | Status: COMPLETED | Results posted: 2020-01-18